Volume 30, Number 6—June 2024
Research
Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States
Isabel Griffin
, Jessica King1, B. Casey Lyons1, Alyson L. Singleton1, Xidong Deng, Beau B. Bruce, and Patricia M. Griffin
, Jessica King1, B. Casey Lyons1, Alyson L. Singleton1, Xidong Deng, Beau B. Bruce, and Patricia M. Griffin
Table 5
Case-fatality rates by age group and sex of patients with SARS-CoV-2 infections, United States, 2020*
| Age group, y | Case-fatality rates including cases for which death status was not known, counted as live, % |
Case-fatality rates among cases for which death status was known, % |
|||
|---|---|---|---|---|---|
| Male | Female | Male | Female | ||
| <1 | 0.04 | 0.06 | 0.04 | 0.07 | |
| 1–4 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 5–14 | 0.00 | 0.01 | 0.01 | 0.01 | |
| 15–24 | 0.03 | 0.01 | 0.03 | 0.02 | |
| 25–34 | 0.09 | 0.05 | 0.11 | 0.06 | |
| 35–44 | 0.2 | 0.1 | 0.3 | 0.2 | |
| 45–54 | 0.7 | 0.3 | 0.8 | 0.4 | |
| 55–64 | 2.0 | 1.0 | 2.4 | 1.2 | |
| 65–74 | 6.0 | 3.6 | 7.2 | 4.3 | |
| 75–84 | 14.7 | 9.8 | 17.5 | 11.8 | |
| >85 | 29.4 | 20.9 | 34.0 | 24.9 | |
| Missing† | 0.1 | 0.0 | 0.1 | 0.0 | |
*Data from 22 jurisdictions that met the study inclusion criteria, CDC line level surveillance dataset, accessed March 17, 2021, based on responses to the CDC 2019 Novel Coronavirus Case Report Form during May 1–December 1, 2020. Reports in which no response was provided about death were excluded from the rate calculation. †Missing indicates that the field was left blank.
1These authors contributed equally to this article.
Page created: May 02, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.